查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1825890

2025年全球紅色生物技術市場報告

Red Biotechnology Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年，紅色生物技術市場將快速成長，到2029年將達到9,378.5億美元，複合年成長率為10.5%。預測期內成長的促進因素包括個人化醫療的擴張、人口老化、研發投入、數位健康整合以及醫療基礎設施的不斷擴展。預測期內的全球趨勢包括生技藥品和生物學名藥的擴張、機器學習的整合、基於微生物組的治療方法的開發、對罕見疾病和孤兒病的關注以及全球合作與夥伴關係。

未來五年的預測成長率為10.5%，較我們先前對該市場的預測略有下降0.7%。這一下降主要源自於美國與其他國家之間關稅的影響。徵收關稅可能對美國生物製藥公司構成重大挑戰，因為它將限制從美國和中國進口的CRISPR（成簇規律間隔短回文重複序列）-Cas9基因編輯套件，阻礙再生醫學試驗，並可能增加治療開發成本。由於互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響，關稅的影響可能更為廣泛。

個人化醫療的需求日益成長，預計紅色生物技術市場將迎來成長。個人化醫療是指根據個人特徵（例如遺傳和生活習慣）客製化治療方案，以最佳化療效並減少副作用。這種需求的促進因素包括：更有效的治療方法的潛力、基因組學的進步、日益複雜的疾病以及支持性法規的訂定。紅色生物技術利用遺傳訊息，根據患者的基因圖譜和疾病特徵量身訂做治療方案，從而促進個人化醫療的發展。例如，個人化醫療聯盟於2024年2月報告稱，FDA在2023年核准了16種針對罕見疾病的新型個人化治療方案，而2022年僅批准了6種。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球紅色生物技術：PESTEL分析（政治、社會、科技、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球紅色生物技術市場：成長率分析
  • 全球紅色生物技術市場表現：規模與成長，2019-2024
  • 全球紅色生物技術市場預測：2024-2029年及2034年規模與成長
  • 全球紅色生物技術：總目標市場（TAM）

第6章 市場細分

  • 全球紅色生物技術市場：依產品、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 單株抗體
  • 多株抗體
  • 重組蛋白
  • 疫苗
  • 基於細胞的免疫療法產品
  • 基因治療產品
  • 細胞治療產品
  • 組織工程產品
  • 其他產品
  • 全球紅色生物技術市場：按應用、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 藥物研發
  • 動物生物技術
  • 環境生物技術
  • 醫學生物技術
  • 工業生物技術
  • 農業生物技術
  • 其他用途
  • 全球紅色生物技術市場：按最終用戶、實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 生物製藥業
  • 契約製造組織 (CMO) 和合約研究組織 (CRO)
  • 其他最終用戶
  • 全球紅色生物技術市場：單株抗體細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 治療性單株抗體
  • 診斷性單株抗體
  • 單株抗體生物相似藥
  • 標靶單株抗體（癌症、自體免疫疾病）
  • 全球紅色生物技術市場：多株抗體（按類型）、實際及預測（2019-2024 年、2024-2029 年、2034 年）
  • 診斷性多多株抗體
  • 治療性多株多株抗體
  • 獸用多株多株抗體
  • 調查多多株抗體
  • 全球紅色生物技術市場：重組蛋白細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 酵素替代療法
  • 生長因子和荷爾蒙
  • 凝血因子濃縮物
  • 干擾素和細胞激素
  • 全球紅色生物技術市場：依疫苗類型細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 預防性疫苗（流感、COVID-19、HPV）
  • 治療性疫苗（癌症疫苗）
  • 基於DNA或RNA的疫苗
  • 蛋白質次單元疫苗
  • 全球紅色生物技術市場：細胞免疫治療產品細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • Car-T細胞療法
  • T細胞受體治療
  • NK細胞療法
  • 基於樹突狀細胞的免疫療法
  • 全球紅色生物技術市場：基因治療產品細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 基因編輯（基於 Crispr 的治療方法）
  • 基於病毒載體的基因治療
  • 基因靜默療法
  • 體內基因治療產品
  • 全球紅色生物技術市場：按細胞治療產品類型、績效和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 幹細胞療法
  • 再生細胞療法（間質幹細胞）
  • 自體細胞治療
  • 同種異體細胞治療
  • 全球紅色生物技術市場：依組織工程產品細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 皮膚和軟骨工程產品
  • 骨骼和肌肉再生產品
  • 心血管組織工程
  • 神經組織工程
  • 全球紅色生物技術市場：依產品類型細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 血液和血液成分（例如血液替代品）
  • 蛋白質治療學
  • 診斷試劑套件和工具（生物標記、檢測試劑）
  • 再生醫學產品

第7章 區域和國家分析

  • 全球紅色生物技術市場：區域表現與預測（2019-2024 年、2024-2029 年及 2034 年）
  • 全球紅色生物技術市場：各國狀況、表現及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 紅色生物技術市場：競爭格局
  • 紅色生物技術市場：公司簡介
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
    • GSK plc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Takeda Pharmaceutical Company Limited
  • Eli Lilly and Company
  • Gilead Sciences
  • Amgen Inc.
  • Merck KGaA
  • Moderna Inc.
  • Regeneron Pharmaceuticals Inc.
  • Astellas Pharma Inc.
  • Biogen Inc.
  • Boehringer Ingelheim International GmbH
  • BioMarin Pharmaceutical Inc.
  • Vir Biotechnology
  • Alnylam Pharmaceuticals, Inc.
  • Ultragenyx Pharmaceutical
  • BioCryst Pharmaceuticals

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年紅色生物技術市場：提供新機會的國家
  • 2029年紅色生物技術市場：細分領域帶來新機會
  • 2029年紅色生物技術市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r31095u

Red biotechnology, a branch of biotechnology, focuses on medical and pharmaceutical applications, utilizing biological systems and organisms to develop products and technologies for healthcare. These include pharmaceuticals, diagnostic tests, and therapies to treat diseases and enhance human health.

The main products in red biotechnology encompass monoclonal antibodies, polyclonal antibodies, recombinant proteins, vaccines, cell-based immunotherapy products, gene therapy products, cell therapy products, tissue-engineered products, among others. Monoclonal antibodies, for instance, are lab-made proteins that mimic the immune system's ability to combat pathogens, finding application in targeted therapies for conditions such as cancer and autoimmune disorders. Red biotechnology spans drug discovery, animal biotechnology, environmental biotechnology, medical biotechnology, industrial biotechnology, agricultural biotechnology, catering to end-users such as the biopharmaceutical industry, contract manufacturing organizations (CMOs), contract research organizations (CROs), research institutes, and more.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The red biotechnology market research report is one of a series of new reports from The Business Research Company that provides red biotechnology market statistics, including the red biotechnology industry global market size, regional shares, competitors with the red biotechnology market share, detailed red biotechnology market segments, market trends, and opportunities, and any further data you may need to thrive in the red biotechnology industry. These red biotechnology market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The red biotechnology market size has grown rapidly in recent years. It will grow from $566.28 billion in 2024 to $629.69 billion in 2025 at a compound annual growth rate (CAGR) of 11.2%. The growth in the historic period can be attributed to advancements in genetic engineering, stem cell research, growth of biotech startups, regulatory frameworks, biotech funding, and investment.

The red biotechnology market size is expected to see rapid growth in the next few years. It will grow to $937.85 billion in 2029 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to the expansion of personalized medicine, the aging population, investment in research and development, digital health integration, and the expansion of healthcare infrastructure. Major trends in the forecast period include the expansion of biologics and biosimilars, integration of machine learning, development of microbiome-based therapies, focus on rare and orphan diseases, global collaboration, and partnerships.

The forecast of 10.5% growth over the next five years reflects a modest reduction of 0.7% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose a significant challenge for U.S. biopharma by restricting access to Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Cas9 gene editing kits imported from Sweden and China, potentially stalling regenerative medicine trials and increasing therapeutic development costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The red biotechnology market is set to experience growth, driven by the increasing demand for personalized medicine. Personalized medicine tailors medical treatment to individual characteristics such as genetics or lifestyle to optimize effectiveness and reduce adverse effects. This demand is fueled by the potential for more effective treatments, advances in genomics, growing disease complexities, and supportive regulations. Red biotechnology facilitates the development of personalized medicines by leveraging genetic information to customize treatments based on a patient's genetic profile and disease attributes. For example, in February 2024, the FDA approved 16 novel personalized therapies for rare diseases in 2023, compared to six in 2022, as reported by the Personalized Medicine Coalition.

Leading companies in the red biotechnology sector are concentrating on developing innovative products such as biosimilars to cater to the rising demand for personalized medicine and tackle disease complexities. Biosimilars are biological products closely resembling existing approved reference biologics, offering cost-effective alternatives. For instance, in June 2022, Amgen Inc. obtained FDA approval for Riabni (rituximab-arrx), a biosimilar to Rituxan (rituximab), for treating adults with moderate to severe rheumatoid arthritis (RA). This milestone underscores the development of biosimilars, designed to mimic existing biological products at lower costs.

In March 2023, Ipsen Biopharmaceuticals Inc. acquired Albireo Pharma Inc. to enhance its Rare Disease portfolio with therapies for rare cholestatic liver diseases. Albireo Pharma Inc. specializes in novel bile acid modulators for orphan pediatric liver diseases, contributing to Ipsen's scientific and commercial capabilities.

Major companies operating in the red biotechnology market are Pfizer Inc., F. Hoffmann-La Roche AG, Bayer AG, Bristol-Myers Squibb Company, GSK plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences, Amgen Inc., Merck KGaA, Moderna Inc., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Biogen Inc., Boehringer Ingelheim International GmbH, BioMarin Pharmaceutical Inc., Vir Biotechnology, Alnylam Pharmaceuticals, Inc., Ultragenyx Pharmaceutical, BioCryst Pharmaceuticals, Sangamo Therapeutics, Inc., Denali Therapeutics, Atara Biotherapeutics, Beam Therapeutics, Umoja Biopharma

North America was the largest region in the red biotechnology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the red biotechnology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the red biotechnology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The red biotechnology market consists of sales of diagnostic testing kits, biological sensors, regenerative medicine, and antibiotics. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Red Biotechnology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on red biotechnology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for red biotechnology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The red biotechnology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Monoclonal Antibodies; Polyclonal Antibodies; Recombinant Proteins; Vaccines; Cell-Based Immunotherapy Products; Gene Therapy Products; Cell Therapy Products; Tissue-Engineered Products; Other Products
  • 2) By Application: Drug Discovery And Development; Animal Biotechnology; Environmental Biotechnology; Medical Biotechnology; Industrial Biotechnology; Agricultural Biotechnology; Other Applications
  • 3) By End-User: Biopharmaceutical Industry; Contract Manufacturing Organization (CMO) And Contract Research Organization (CRO) Research Institutes; Other End Users
  • Subsegments:
  • 1) By Monoclonal Antibodies: Therapeutic Monoclonal Antibodies; Diagnostic Monoclonal Antibodies; Biosimilars Of Monoclonal Antibodies; Targeted Monoclonal Antibodies (For Cancer, Autoimmune Diseases)
  • 2) By Polyclonal Antibodies: Diagnostic Polyclonal Antibodies; Therapeutic Polyclonal Antibodies; Veterinary Polyclonal Antibodies; Research Polyclonal Antibodies
  • 3) By Recombinant Proteins: Enzyme Replacement Therapies; Growth Factors And Hormones; Clotting Factor Products; Interferons And Cytokines
  • 4) By Vaccines: Preventive Vaccines (For Influenza, Covid-19, Hpv); Therapeutic Vaccines (Cancer Vaccines); Dna Or Rna-Based Vaccines; Protein Subunit Vaccines
  • 5) By Cell-Based Immunotherapy Products: Car-T-Cell Therapies; T-Cell Receptor Therapies; Nk Cell Therapies; Dendritic Cell-Based Immunotherapies
  • 6) By Gene Therapy Products: Gene Editing (Crispr-Based Therapies); Viral Vector-Based Gene Therapies; Gene Silencing Therapies; In Vivo Gene Therapy Products
  • 7) By Cell Therapy Products: Stem Cell Therapies; Regenerative Cell Therapies (Mesenchymal Stem Cells); Autologous Cell Therapies; Allogeneic Cell Therapies
  • 8) By Tissue-Engineered Products: Skin And Cartilage Engineered Products; Bone And Muscle Regenerative Products; Cardiovascular Tissue Engineering; Neural Tissue Engineering
  • 9) By Other Products: Blood And Blood Components (E.g., Blood Substitutes); Protein Therapeutics; Diagnostic Kits And Tools (Biomarkers, Assays); Regenerative Medicine Products
  • Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche AG; Bayer AG; Bristol-Myers Squibb Company; GSK plc.; Takeda Pharmaceutical Company Limited; Eli Lilly and Company; Gilead Sciences; Amgen Inc.; Merck KGaA; Moderna Inc.; Regeneron Pharmaceuticals Inc.; Astellas Pharma Inc.; Biogen Inc.; Boehringer Ingelheim International GmbH; BioMarin Pharmaceutical Inc.; Vir Biotechnology; Alnylam Pharmaceuticals, Inc.; Ultragenyx Pharmaceutical; BioCryst Pharmaceuticals; Sangamo Therapeutics, Inc.; Denali Therapeutics; Atara Biotherapeutics; Beam Therapeutics; Umoja Biopharma
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Red Biotechnology Market Characteristics

3. Red Biotechnology Market Trends And Strategies

4. Red Biotechnology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Red Biotechnology Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Red Biotechnology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Red Biotechnology Market Growth Rate Analysis
  • 5.4. Global Red Biotechnology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Red Biotechnology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Red Biotechnology Total Addressable Market (TAM)

6. Red Biotechnology Market Segmentation

  • 6.1. Global Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Monoclonal Antibodies
  • Polyclonal Antibodies
  • Recombinant Proteins
  • Vaccines
  • Cell-Based Immunotherapy Products
  • Gene Therapy Products
  • Cell Therapy Products
  • Tissue-Engineered Products
  • Other Products
  • 6.2. Global Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug Discovery And Development
  • Animal Biotechnology
  • Environmental Biotechnology
  • Medical Biotechnology
  • Industrial Biotechnology
  • Agricultural Biotechnology
  • Other Applications
  • 6.3. Global Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Biopharmaceutical Industry
  • Contract Manufacturing Organization (CMO) And Contract Research Organization (CRO) Research Institutes
  • Other End Users
  • 6.4. Global Red Biotechnology Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Therapeutic Monoclonal Antibodies
  • Diagnostic Monoclonal Antibodies
  • Biosimilars Of Monoclonal Antibodies
  • Targeted Monoclonal Antibodies (For Cancer, Autoimmune Diseases)
  • 6.5. Global Red Biotechnology Market, Sub-Segmentation Of Polyclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostic Polyclonal Antibodies
  • Therapeutic Polyclonal Antibodies
  • Veterinary Polyclonal Antibodies
  • Research Polyclonal Antibodies
  • 6.6. Global Red Biotechnology Market, Sub-Segmentation Of Recombinant Proteins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Enzyme Replacement Therapies
  • Growth Factors And Hormones
  • Clotting Factor Products
  • Interferons And Cytokines
  • 6.7. Global Red Biotechnology Market, Sub-Segmentation Of Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Preventive Vaccines (For Influenza, Covid-19, Hpv)
  • Therapeutic Vaccines (Cancer Vaccines)
  • Dna Or Rna-Based Vaccines
  • Protein Subunit Vaccines
  • 6.8. Global Red Biotechnology Market, Sub-Segmentation Of Cell-Based Immunotherapy Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Car-T-Cell Therapies
  • T-Cell Receptor Therapies
  • Nk Cell Therapies
  • Dendritic Cell-Based Immunotherapies
  • 6.9. Global Red Biotechnology Market, Sub-Segmentation Of Gene Therapy Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Gene Editing (Crispr-Based Therapies)
  • Viral Vector-Based Gene Therapies
  • Gene Silencing Therapies
  • In Vivo Gene Therapy Products
  • 6.10. Global Red Biotechnology Market, Sub-Segmentation Of Cell Therapy Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Stem Cell Therapies
  • Regenerative Cell Therapies (Mesenchymal Stem Cells)
  • Autologous Cell Therapies
  • Allogeneic Cell Therapies
  • 6.11. Global Red Biotechnology Market, Sub-Segmentation Of Tissue-Engineered Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Skin And Cartilage Engineered Products
  • Bone And Muscle Regenerative Products
  • Cardiovascular Tissue Engineering
  • Neural Tissue Engineering
  • 6.12. Global Red Biotechnology Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood And Blood Components (E.g., Blood Substitutes)
  • Protein Therapeutics
  • Diagnostic Kits And Tools (Biomarkers, Assays)
  • Regenerative Medicine Products

7. Red Biotechnology Market Regional And Country Analysis

  • 7.1. Global Red Biotechnology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Red Biotechnology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Red Biotechnology Market

  • 8.1. Asia-Pacific Red Biotechnology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Red Biotechnology Market

  • 9.1. China Red Biotechnology Market Overview
  • 9.2. China Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Red Biotechnology Market

  • 10.1. India Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Red Biotechnology Market

  • 11.1. Japan Red Biotechnology Market Overview
  • 11.2. Japan Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Red Biotechnology Market

  • 12.1. Australia Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Red Biotechnology Market

  • 13.1. Indonesia Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Red Biotechnology Market

  • 14.1. South Korea Red Biotechnology Market Overview
  • 14.2. South Korea Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Red Biotechnology Market

  • 15.1. Western Europe Red Biotechnology Market Overview
  • 15.2. Western Europe Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Red Biotechnology Market

  • 16.1. UK Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Red Biotechnology Market

  • 17.1. Germany Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Red Biotechnology Market

  • 18.1. France Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Red Biotechnology Market

  • 19.1. Italy Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Red Biotechnology Market

  • 20.1. Spain Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Red Biotechnology Market

  • 21.1. Eastern Europe Red Biotechnology Market Overview
  • 21.2. Eastern Europe Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Red Biotechnology Market

  • 22.1. Russia Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Red Biotechnology Market

  • 23.1. North America Red Biotechnology Market Overview
  • 23.2. North America Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Red Biotechnology Market

  • 24.1. USA Red Biotechnology Market Overview
  • 24.2. USA Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Red Biotechnology Market

  • 25.1. Canada Red Biotechnology Market Overview
  • 25.2. Canada Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Red Biotechnology Market

  • 26.1. South America Red Biotechnology Market Overview
  • 26.2. South America Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Red Biotechnology Market

  • 27.1. Brazil Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Red Biotechnology Market

  • 28.1. Middle East Red Biotechnology Market Overview
  • 28.2. Middle East Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Red Biotechnology Market

  • 29.1. Africa Red Biotechnology Market Overview
  • 29.2. Africa Red Biotechnology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Red Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Red Biotechnology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Red Biotechnology Market Competitive Landscape And Company Profiles

  • 30.1. Red Biotechnology Market Competitive Landscape
  • 30.2. Red Biotechnology Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. GSK plc. Overview, Products and Services, Strategy and Financial Analysis

31. Red Biotechnology Market Other Major And Innovative Companies

  • 31.1. Takeda Pharmaceutical Company Limited
  • 31.2. Eli Lilly and Company
  • 31.3. Gilead Sciences
  • 31.4. Amgen Inc.
  • 31.5. Merck KGaA
  • 31.6. Moderna Inc.
  • 31.7. Regeneron Pharmaceuticals Inc.
  • 31.8. Astellas Pharma Inc.
  • 31.9. Biogen Inc.
  • 31.10. Boehringer Ingelheim International GmbH
  • 31.11. BioMarin Pharmaceutical Inc.
  • 31.12. Vir Biotechnology
  • 31.13. Alnylam Pharmaceuticals, Inc.
  • 31.14. Ultragenyx Pharmaceutical
  • 31.15. BioCryst Pharmaceuticals

32. Global Red Biotechnology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Red Biotechnology Market

34. Recent Developments In The Red Biotechnology Market

35. Red Biotechnology Market High Potential Countries, Segments and Strategies

  • 35.1 Red Biotechnology Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Red Biotechnology Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Red Biotechnology Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer